A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Neoss® Group Opens Two New Sales Offices in Europe

Neoss® Group has announced the opening of two new sales organizations, Neoss Norden AB and Neoss UK & Ireland Ltd. These two organizations will ensure our continued growth and commercialization of our expanding product portfolio in the region. Most important, it will help us to better support dental professionals and their patients in Europe. Both organizations will begin operations December 1st, 2022.

“These two organizations are an important foundation to be able to support our growing customer base in Europe. Increasing our footprint in these markets is important to us, this is where it all started for Neoss. The Nordic region is particularly important due to it is where our implants are produced, our R&D is located and the dental implant heritage.”

Dr. Robert Gottlander, President and CEO of Neoss Group

As previously announced, Albin Wahlstrand will be the Managing Director for Neoss Norden AB. He brings over 20 years of experience within the dental industry and has worked with every aspect of the dental business including sales, product management, and business development.

Neoss Norden AB organization is located in the Biotech Center building next to the Institute of Odontology, University of Gothenburg. Neoss Norden AB, Arvid Wallgrens backe 20, 413 46 Göteborg, Sweden.

Fernando Spieler, current National Sales Manager will be promoted to Managing Director for the newly formed Neoss UK & Ireland Ltd. He has been part of the Neoss family for almost 2 years and before this has over 15 years of experience within the medical device industry.

Neoss UK & Ireland Ltd organization is in the same building as Neoss Ltd, Windsor House, Cornwall Rd, Harrogate HG1 2PW, United Kingdom.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy